The Rapid Response Maternal-Infant Clinical and Biospecimen Access Platform, or Biorepository Study, is a project aimed at better understanding the burden of COVID-19 on pregnancy. To do this, we have established a Biorepository of data and samples for future studies related to COVID-19 in pregnant populations.
Recruitment for the Biorepository Study is now closed. For further information, please contact us via email at email@example.com
The Biorepository is associated with CANCOVID-Preg and funded by the UBC Strategic Investment Fund and the Canadian Institutes of Health Research. The Biorepository is also registered with the Canadian Tissue Repository Network (https://biobanking.org/biobanks/view/562)